Longitudinal trajectory analysis performed by linear mixed-effect models showed that participants with higher levels of plasma adiponectin presented accelerated cognitive decline and cortical thinning only in the Aβ (+) status (Table 4 and Fig. 1). The gene discussed is ADIPOQ; the disease is Mental deterioration.